Predictive Oncology receives Nasdaq delisting notice for failure to meet equity requirement

Axe Compute Inc.

Nasdaq notified Predictive Oncology June 9 of delisting for failing to meet $2.5M stockholders' equity requirement.
Company could not complete compliance plan within 180-day extension granted by Nasdaq.
Trading suspended June 18 unless appeal requested by June 16; company appealed to Nasdaq Hearings Panel.
Appeal stays suspension; Panel may grant exception up to 180 days.
No assurance of continued listing; company evaluating all options.

item 3.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.